Hidradenitis suppurativa and the association with hematological malignancies

A review of 2 cases

Bahman Sotoodian, Mariam Abbas, Alain Brassard

Research output: Contribution to journalArticle

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting skin sites with a high density of apocrine glands. HS commonly presents after puberty, with most patients diagnosed in the second decade of their life. Several studies have investigated smoking, obesity, hypertension, diabetes, and dyslipidemia as possible underlying risk factors for HS. However, we encountered 2 patients with a long-standing history of untreated leukemia who developed late-onset HS. Objective: To investigate the presence of malignancy as an underlying risk factor for development of HS. Method: The PubMed and Scopus databases were searched for keywords such as hidradenitis suppurativa, malignancy, cancer, and epidemiology. Observation: Only 1 retrospective Swedish study with 2119 patients investigated the prevalence of cancer, including 6 hematopoietic malignancies, in HS patients. However, the study did not assess the timeline of developing HS in relation to the cancer diagnosis. We report 2 patients with a long-standing history of hematopoietic cancers who received no continuous treatments for their malignancies and developed late-onset HS: A 60-year-old male patient with hairy cell leukemia and a 68-year-old male patient with chronic lymphocytic leukemia who developed HS later in life. Conclusion: Multiple epidemiologic studies found the average age of HS diagnosis to be well prior to the fourth decade of life. The latency of the HS diagnosis as well as the presence of long-standing leukemia in both of our patients raises the necessity for assessing the possibility of malignancy, especially hematopoietic cancer, as a risk factor for HS. Limitation: This is a small retrospective analysis including only 2 patients. Larger studies would better assess the role of malignancy, leukemia in particular, as a possible risk factor for development of HS.

Original languageEnglish (US)
Pages (from-to)158-161
Number of pages4
JournalJournal of Cutaneous Medicine and Surgery
Volume21
Issue number2
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Hidradenitis Suppurativa
Hematologic Neoplasms
Neoplasms
Leukemia
Apocrine Glands
Hairy Cell Leukemia
B-Cell Chronic Lymphocytic Leukemia
Puberty
Dyslipidemias

Keywords

  • acne
  • adalimumab
  • hematologic malignancies
  • hidradenitis suppurativa
  • lymphoma

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Hidradenitis suppurativa and the association with hematological malignancies : A review of 2 cases. / Sotoodian, Bahman; Abbas, Mariam; Brassard, Alain.

In: Journal of Cutaneous Medicine and Surgery, Vol. 21, No. 2, 01.01.2017, p. 158-161.

Research output: Contribution to journalArticle

@article{46ebe2bca37c4a8588234267c0f03e4c,
title = "Hidradenitis suppurativa and the association with hematological malignancies: A review of 2 cases",
abstract = "Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting skin sites with a high density of apocrine glands. HS commonly presents after puberty, with most patients diagnosed in the second decade of their life. Several studies have investigated smoking, obesity, hypertension, diabetes, and dyslipidemia as possible underlying risk factors for HS. However, we encountered 2 patients with a long-standing history of untreated leukemia who developed late-onset HS. Objective: To investigate the presence of malignancy as an underlying risk factor for development of HS. Method: The PubMed and Scopus databases were searched for keywords such as hidradenitis suppurativa, malignancy, cancer, and epidemiology. Observation: Only 1 retrospective Swedish study with 2119 patients investigated the prevalence of cancer, including 6 hematopoietic malignancies, in HS patients. However, the study did not assess the timeline of developing HS in relation to the cancer diagnosis. We report 2 patients with a long-standing history of hematopoietic cancers who received no continuous treatments for their malignancies and developed late-onset HS: A 60-year-old male patient with hairy cell leukemia and a 68-year-old male patient with chronic lymphocytic leukemia who developed HS later in life. Conclusion: Multiple epidemiologic studies found the average age of HS diagnosis to be well prior to the fourth decade of life. The latency of the HS diagnosis as well as the presence of long-standing leukemia in both of our patients raises the necessity for assessing the possibility of malignancy, especially hematopoietic cancer, as a risk factor for HS. Limitation: This is a small retrospective analysis including only 2 patients. Larger studies would better assess the role of malignancy, leukemia in particular, as a possible risk factor for development of HS.",
keywords = "acne, adalimumab, hematologic malignancies, hidradenitis suppurativa, lymphoma",
author = "Bahman Sotoodian and Mariam Abbas and Alain Brassard",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/1203475416668161",
language = "English (US)",
volume = "21",
pages = "158--161",
journal = "Journal of Cutaneous Medicine and Surgery",
issn = "1203-4754",
publisher = "Decker Publishing",
number = "2",

}

TY - JOUR

T1 - Hidradenitis suppurativa and the association with hematological malignancies

T2 - A review of 2 cases

AU - Sotoodian, Bahman

AU - Abbas, Mariam

AU - Brassard, Alain

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting skin sites with a high density of apocrine glands. HS commonly presents after puberty, with most patients diagnosed in the second decade of their life. Several studies have investigated smoking, obesity, hypertension, diabetes, and dyslipidemia as possible underlying risk factors for HS. However, we encountered 2 patients with a long-standing history of untreated leukemia who developed late-onset HS. Objective: To investigate the presence of malignancy as an underlying risk factor for development of HS. Method: The PubMed and Scopus databases were searched for keywords such as hidradenitis suppurativa, malignancy, cancer, and epidemiology. Observation: Only 1 retrospective Swedish study with 2119 patients investigated the prevalence of cancer, including 6 hematopoietic malignancies, in HS patients. However, the study did not assess the timeline of developing HS in relation to the cancer diagnosis. We report 2 patients with a long-standing history of hematopoietic cancers who received no continuous treatments for their malignancies and developed late-onset HS: A 60-year-old male patient with hairy cell leukemia and a 68-year-old male patient with chronic lymphocytic leukemia who developed HS later in life. Conclusion: Multiple epidemiologic studies found the average age of HS diagnosis to be well prior to the fourth decade of life. The latency of the HS diagnosis as well as the presence of long-standing leukemia in both of our patients raises the necessity for assessing the possibility of malignancy, especially hematopoietic cancer, as a risk factor for HS. Limitation: This is a small retrospective analysis including only 2 patients. Larger studies would better assess the role of malignancy, leukemia in particular, as a possible risk factor for development of HS.

AB - Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting skin sites with a high density of apocrine glands. HS commonly presents after puberty, with most patients diagnosed in the second decade of their life. Several studies have investigated smoking, obesity, hypertension, diabetes, and dyslipidemia as possible underlying risk factors for HS. However, we encountered 2 patients with a long-standing history of untreated leukemia who developed late-onset HS. Objective: To investigate the presence of malignancy as an underlying risk factor for development of HS. Method: The PubMed and Scopus databases were searched for keywords such as hidradenitis suppurativa, malignancy, cancer, and epidemiology. Observation: Only 1 retrospective Swedish study with 2119 patients investigated the prevalence of cancer, including 6 hematopoietic malignancies, in HS patients. However, the study did not assess the timeline of developing HS in relation to the cancer diagnosis. We report 2 patients with a long-standing history of hematopoietic cancers who received no continuous treatments for their malignancies and developed late-onset HS: A 60-year-old male patient with hairy cell leukemia and a 68-year-old male patient with chronic lymphocytic leukemia who developed HS later in life. Conclusion: Multiple epidemiologic studies found the average age of HS diagnosis to be well prior to the fourth decade of life. The latency of the HS diagnosis as well as the presence of long-standing leukemia in both of our patients raises the necessity for assessing the possibility of malignancy, especially hematopoietic cancer, as a risk factor for HS. Limitation: This is a small retrospective analysis including only 2 patients. Larger studies would better assess the role of malignancy, leukemia in particular, as a possible risk factor for development of HS.

KW - acne

KW - adalimumab

KW - hematologic malignancies

KW - hidradenitis suppurativa

KW - lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85018171699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018171699&partnerID=8YFLogxK

U2 - 10.1177/1203475416668161

DO - 10.1177/1203475416668161

M3 - Article

VL - 21

SP - 158

EP - 161

JO - Journal of Cutaneous Medicine and Surgery

JF - Journal of Cutaneous Medicine and Surgery

SN - 1203-4754

IS - 2

ER -